Brief: Il Dong Pharmaceutical Q4 Consolidated Operating Loss 3 Billion Won, Up 87% From Year Earlier
08/02/2024 09:18
Il Dong Pharmaceutical Co Ltd 249420.KS :
* IL DONG PHARMACEUTICAL: Q4 CONSOLIDATED OPERATING LOSS 3
BILLION
WON, UP 87% FROM YEAR EARLIER
Source text for Eikon: ID:
Further company coverage: 249420.KS
Recent news on Il Dong Pharmaceutical
See all newsBrief: Il Dong Pharmaceutical Q4 Operating Profit 8 Billion Won, Down 5.7% From Year Earlier
To Divest 15.85 Billion Won Worth Of Shares In D&D Pharmatech
Brief: Il Dong Pharmaceutical Q3 Operating Profit 6.8 Billion Won, Up 87.6% From Year Earlier
Brief: Il Dong Pharmaceutical Q2 Operating Profit 596 Million Won, Down 41.4% From Year Earlier
Brief: Il Dong Pharmaceutical Q1 Operating Profit 4.2 Billion Won, Up 4275% From Year Earlier